US Patent Issued to EISAI R&D MANAGEMENT on March 3 for "System for enhancing therapeutic compliance of the anti-cancer compound E7766" (Massachusetts Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,600, issued on March 3, was assigned to EISAI R&D MANAGEMENT Co. LTD. (Tokyo).

"System for enhancing therapeutic compliance of the anti-cancer compound E7766" was invented by Rongrong Jiang (Medford, Mass.) and Vaishali Dixit (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are systems and methods for reducing medication error caused by a drug-drug interaction between Compound 1 (E7766) and an OATP inhibitor. Methods for monitoring the exposure of Compound 1 in a patient and preventing overexposure of Compound 1 in a patient are also disclosed."

The patent was filed on July 1, 2020, under Application No. 17/597,199....